Best Medical International, Inc. (BMI) welcomed new Sr. Business Advisor Volker Stieber, as well as new Business Advisors Timothy Prosser, Stephen Sledge and Francisco (Paco) Hernandez to the team at BMI and all TeamBest Global Companies. All four advisors will work closely with Krishan Suthanthiran, Founder and President of BMI, as well as with the Global TeamBest Management.
Stieber’s initial focus will be to advise on the development and manufacturing of a new line of advanced economical Linear Accelerators for cancer treatment. He will also participate in the company’s growth strategies encompassing the many products and services offered by BMI. He brings over 40 years of experience in Radiation Oncology with more than 25 years of Senior Management experience as Executive Officer in various divisions of the world’s largest suppliers of medical equipment.
“I first met Volker in early 1980 when he was at Siemens Medical Laboratories and he brings a wealth of knowledge, manufacturing and business experience to TeamBest,” stated Suthanthiran. “Volker will be a great asset to further support our efforts as we develop and grow our Linear Accelerator product line.”
Sledge will initially focus on business development, marketing, and sales of BMI products for proton/particle therapy and cyclotron applications. Additionally, Stephen will provide input into the new line of advanced economical Linear Accelerators for treating cancer and participate in the company’s growth strategies for Best cyclotron systems, particle therapy, and proton treatment systems.
With over 30 years of experience in the medical device industry, specifically with the commercial side of proton therapy and radiation therapy treatment systems and software, Sledge brings a wealth of business and technical competencies, including a background in physics and electrical engineering.
“I first met Stephen Sledge nearly 10 years ago and he has shown a consistent success in taking products and initiatives to market that increased sales and market share,” stated Suthanthiran. “Stephen will be a great asset working alongside the strong team of Business Advisors we have assembled here at TeamBest as we grow our Cyclotron, Particle Therapy, and Proton Therapy product line.
Prosser will focus on the development, marketing, and commercialization of BMI’s new line of advanced economical Linear Accelerators for treating cancer. He brings nearly 40 years of expertise in the medical device industry with experience and success in service, sales, product management, marketing, education and training. As a well-respected member of the radiation oncology community, Prosser has worked closely with ASTRO and AAPM on standards and safety committees.
“Tim is a highly experienced oncology professional with a comprehensive background providing inspirational, operational, and global leadership in the Oncology Healthcare space,” said Suthanthiran. “Tim will be a great asset working alongside the strong team of Business Advisors we have assembled here at TeamBest as we grow our Linear Accelerator product line.”
Hernandez will focus on the development and manufacturing of BMI’s new line of advanced economical Linear Accelerators for treating cancer. He has over 35 years of experience in the radiation oncology business and brings extensive experience in LINAC development for treatment of cancer. He’s led advanced engineering teams in the design and manufacturing of Linear Accelerators, MR-Linear Accelerators, and LINAC Control System development from concept to product launch. In addition, he’s been granted many patents in the field of Linear Accelerator design and development.
“I am extremely pleased that Paco agreed to assist BMI as Technical Business Advisor as he brings a wealth of knowledge, manufacturing and linear accelerator domain knowledge to TeamBest,” stated Suthanthiran. “Paco will be a great asset to further support our efforts as we develop and grow our Linear Accelerator product line.”Back To Top
Best Medical International and TeamBest Global Companies Add New Business Advisors. Appl Rad Oncol.